Biotalys N.V (BTLS) | Stock Overview & Key Data
Biotalys N.V Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €7.98 on June 28, 2021
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Biotalys N.V
BTLS
|
87.53M Small-cap | 3.88% | 12.24% | 25.88% | -9.83% | -11.08% | -26.17% | -46.80% | -54.86% | -54.86% | -54.86% | -54.86% |
|
Tessenderlo Group NV
TESB
|
1.26B Large-cap | 2.25% | -4.88% | -19.33% | -19.49% | -21.95% | -21.73% | -32.50% | -40.93% | -30.83% | -7.92% | -7.92% |
|
Syneos Health
SYENS
|
5.71B Large-cap | 6.05% | 7.23% | 51.55% | -3.98% | -3.46% | -0.90% | -29.74% | -29.74% | -29.74% | -29.74% | -29.74% |
|
Titan Cement
TITC
|
3.46B Large-cap | 9.22% | 12.73% | 21.41% | 14.38% | 0.00% | 32.23% | 205.39% | 208.65% | 178.61% | 178.61% | 178.61% |
|
Solvay SA
SOLB
|
2.89B Large-cap | 5.02% | 3.74% | 3.42% | 1.04% | -0.51% | -9.40% | -74.08% | -74.94% | -69.29% | -67.66% | -67.66% |
|
Azelis Group NV
AZE
|
2.52B Large-cap | 1.17% | -3.18% | 40.68% | 10.94% | 10.71% | -22.45% | -52.85% | -62.75% | -62.75% | -62.75% | -62.75% |
Ownership & Short Interest
Calculate Your Biotalys N.V Investment Returns
Long-Term Investment Performance Analysis
Biotalys N.V stock price in Jun 2021 was €7.00, A €1,000.00 lump sum investment in Biotalys N.V made 5 years ago would be worth approximately €458.57 today, representing a negative return of -54.14%. This translates to an annualized return (CAGR) of -14.54%.
4 Years 11 Months Investment Scenario (Jun 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BTLS's 52-week high and low?
- In the last 52 weeks, Biotalys N.V reached a high of €5.50 (on June 27, 2025) and a low of €1.56 (on March 23, 2026).
- What is the market cap and P/E ratio for BTLS?
- Curious about Biotalys N.V's size and valuation? Its market capitalization stands at 87.53M. When it comes to valuation, the P/E ratio (trailing twelve months) is -5.82, and the forward P/E (looking ahead) is -13.12.
- Does BTLS pay dividends? If so, what's the yield?
- As for dividends, Biotalys N.V isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Biotalys N.V's main competitors or similar companies to consider before investing?
When looking at Biotalys N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Tessenderlo Group NV
TESB1.26B Basic Materials Agricultural Inputs -21.73% -32.50% Syneos Health
SYENS5.71B Basic Materials Chemicals -0.90% -29.74% Titan Cement
TITC3.46B Basic Materials Building Materials 32.23% 205.39% Solvay SA
SOLB2.89B Basic Materials Chemicals -9.40% -74.08% Azelis Group NV
AZE2.52B Basic Materials Specialty Chemicals -22.45% -52.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Biotalys N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Biotalys N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -75.33%, the Debt to Equity ratio from the most recent quarter is 21.67, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for BTLS?
- Looking at Biotalys N.V's growth, its revenue over the trailing twelve months (TTM) was €-73K. Compared to the same quarter last year (YoY), quarterly revenue grew by -52.50%, and quarterly earnings saw a YoY growth of N/A.
- How much of BTLS stock is held by insiders and institutions?
- Wondering who owns Biotalys N.V stock? Company insiders (like executives and directors) hold about 47.72% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 21.37%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.